78 related articles for article (PubMed ID: 34145469)
21. Profound Hypoglycemia and High Anion Gap Metabolic Acidosis in a Pediatric Leukemic Patient Receiving 6-Mercaptopurine.
O'Shea M; Kuhn A; Creo AL; Kohorst M; Ferdjallah A
Children (Basel); 2024 Jan; 11(2):. PubMed ID: 38397272
[TBL] [Abstract][Full Text] [Related]
22. Mitigating immortal-time bias: exploring osteonecrosis and survival in pediatric ALL - AALL0232 trial insights.
Srinivasan S; Keerthivasagam S
Leukemia; 2024 May; 38(5):1187-1188. PubMed ID: 38548961
[No Abstract] [Full Text] [Related]
23. Poverty and relapse risk in children with acute lymphoblastic leukemia: a Children's Oncology Group study AALL03N1 report.
Wadhwa A; Chen Y; Hageman L; Hoppmann A; Angiolillo A; Dickens DS; Neglia JP; Ravindranath Y; Ritchey AK; Termuhlen A; Wong FL; Landier W; Bhatia S
Blood; 2023 Jul; 142(3):221-229. PubMed ID: 37070673
[TBL] [Abstract][Full Text] [Related]
24. Hybrid Email and Outpatient Clinics to Optimize Maintenance Therapy in Acute Lymphoblastic Leukemia.
Mungle T; Mahadevan A; Das P; Mehta AK; Gogoi MP; Jana B; Ghara N; Ghosh D; Saha V; Krishnan S
J Pediatr Hematol Oncol; 2024 Jan; 46(1):39-45. PubMed ID: 38096154
[TBL] [Abstract][Full Text] [Related]
25. Osteonecrosis in Adults With Acute Lymphoblastic Leukemia: An Unmet Clinical Need.
Kuhlen M; Kunstreich M; Gökbuget N
Hemasphere; 2021 Apr; 5(4):e544. PubMed ID: 33718802
[TBL] [Abstract][Full Text] [Related]
26. A call for a randomized trial of prophylactic bisphosphonate for decreasing the incidence of osteonecrosis in patients with acute lymphoblastic leukemia.
Bostrom B
Pediatr Blood Cancer; 2024 Jun; 71(6):e30968. PubMed ID: 38520682
[No Abstract] [Full Text] [Related]
27. From niche to blockbuster: a greater role for allopurinol in maintenance treatment of acute lymphoblastic leukemia.
Stanulla M
Haematologica; 2024 May; ():. PubMed ID: 38721742
[TBL] [Abstract][Full Text] [Related]
28. DNA-thioguanine concentration and relapse risk in children and young adults with acute lymphoblastic leukemia: an IPD meta-analysis.
Toksvang LN; Grell K; Nersting J; Degn M; Nielsen SN; Abrahamsson J; Lund B; Kanerva J; Jónsson ÓG; Lepik K; Vaitkevičienė G; Griškevičius L; Quist-Paulsen P; Vora A; Moorman AV; Murdy D; Zimmermann M; Möricke A; Bostrom B; Joshi J; Hjalgrim LL; Dalhoff KP; Als-Nielsen B; Schmiegelow K
Leukemia; 2022 Jan; 36(1):33-41. PubMed ID: 34175901
[TBL] [Abstract][Full Text] [Related]
29. Endothelial dysfunction and thromboembolism in children, adolescents, and young adults with acute lymphoblastic leukemia.
Andrés-Jensen L; Grell K; Rank CU; Albertsen BK; Tuckuviene R; Linnemann Nielsen R; Lynggaard LS; Jarvis KB; Quist-Paulsen P; Trakymiene SS; Semaškevičienė R; Saks K; Jonsson OG; Frandsen TL; Johansson PI; Schmiegelow K
Leukemia; 2022 Feb; 36(2):361-369. PubMed ID: 34389803
[TBL] [Abstract][Full Text] [Related]
30. Humanized CD19-Targeted Chimeric Antigen Receptor (CAR) T Cells in CAR-Naive and CAR-Exposed Children and Young Adults With Relapsed or Refractory Acute Lymphoblastic Leukemia.
Myers RM; Li Y; Barz Leahy A; Barrett DM; Teachey DT; Callahan C; Fasano CC; Rheingold SR; DiNofia A; Wray L; Aplenc R; Baniewicz D; Liu H; Shaw PA; Pequignot E; Getz KD; Brogdon JL; Fesnak AD; Siegel DL; Davis MM; Bartoszek C; Lacey SF; Hexner EO; Chew A; Wertheim GB; Levine BL; June CH; Grupp SA; Maude SL
J Clin Oncol; 2021 Sep; 39(27):3044-3055. PubMed ID: 34156874
[TBL] [Abstract][Full Text] [Related]
31. Individual prediction of nonadherence to oral mercaptopurine in children with acute lymphoblastic leukemia: Results from COG AALL03N1.
Hoppmann AL; Chen Y; Landier W; Hageman L; Evans WE; Wong FL; Relling MV; Bhatia S
Cancer; 2021 Oct; 127(20):3832-3839. PubMed ID: 34161608
[TBL] [Abstract][Full Text] [Related]
32. Continuous Complete Remission in Two Patients with Acute Lymphoblastic Leukemia and Severe Fungal Infection Following Short-Term, Dose-Reduced Chemotherapy.
Lüke F; Harrer DC; Hahn J; Grube M; Pukrop T; Herr W; Reichle A; Heudobler D
Front Pharmacol; 2021; 12():599552. PubMed ID: 34149402
[TBL] [Abstract][Full Text] [Related]
33. Optimizing thiopurine therapy in children with acute lymphoblastic leukemia: A promising "MINT" sequencing strategy and therapeutic "DNA-TG" monitoring.
Guo HL; Zhao YT; Wang WJ; Dong N; Hu YH; Zhang YY; Chen F; Zhou L; Li T
Front Pharmacol; 2022; 13():941182. PubMed ID: 36238550
[TBL] [Abstract][Full Text] [Related]
34. Thiopurine Enhanced ALL Maintenance (TEAM): study protocol for a randomized study to evaluate the improvement in disease-free survival by adding very low dose 6-thioguanine to 6-mercaptopurine/methotrexate-based maintenance therapy in pediatric and adult patients (0-45 years) with newly diagnosed B-cell precursor or T-cell acute lymphoblastic leukemia treated according to the intermediate risk-high group of the ALLTogether1 protocol.
Toksvang LN; Als-Nielsen B; Bacon C; Bertasiute R; Duarte X; Escherich G; Helgadottir EA; Johannsdottir IR; Jónsson ÓG; Kozlowski P; Langenskjöld C; Lepik K; Niinimäki R; Overgaard UM; Punab M; Räty R; Segers H; van der Sluis I; Smith OP; Strullu M; Vaitkevičienė G; Wik HS; Heyman M; Schmiegelow K
BMC Cancer; 2022 May; 22(1):483. PubMed ID: 35501736
[TBL] [Abstract][Full Text] [Related]
35. Maintenance therapy and risk of osteonecrosis in children and young adults with acute lymphoblastic leukemia: a NOPHO ALL2008 sub-study.
Toksvang LN; Andrés-Jensen L; Rank CU; Niinimäki R; Nersting J; Nielsen SN; Mogensen SS; Harila-Saari A; Abrahamsson J; Joelsson J; Overgaard UM; Quist-Paulsen P; Griškevičius L; Jónsson ÓG; Vaitkevičienė G; Frandsen TL; Toft N; Grell K; Schmiegelow K
Cancer Chemother Pharmacol; 2021 Nov; 88(5):911-917. PubMed ID: 34145469
[TBL] [Abstract][Full Text] [Related]
36. DNA-thioguanine nucleotide concentration and relapse-free survival during maintenance therapy of childhood acute lymphoblastic leukaemia (NOPHO ALL2008): a prospective substudy of a phase 3 trial.
Nielsen SN; Grell K; Nersting J; Abrahamsson J; Lund B; Kanerva J; Jónsson ÓG; Vaitkeviciene G; Pruunsild K; Hjalgrim LL; Schmiegelow K
Lancet Oncol; 2017 Apr; 18(4):515-524. PubMed ID: 28258828
[TBL] [Abstract][Full Text] [Related]
37. Risk of relapse in childhood acute lymphoblastic leukemia is related to RBC methotrexate and mercaptopurine metabolites during maintenance chemotherapy. Nordic Society for Pediatric Hematology and Oncology.
Schmiegelow K; Schrøder H; Gustafsson G; Kristinsson J; Glomstein A; Salmi T; Wranne L
J Clin Oncol; 1995 Feb; 13(2):345-51. PubMed ID: 7531219
[TBL] [Abstract][Full Text] [Related]
38. Myelotoxicity, pharmacokinetics, and relapse rate with methotrexate/6-mercaptopurine maintenance therapy of childhood acute lymphoblastic leukemia.
Schmiegelow K; Ifversen M
Pediatr Hematol Oncol; 1996; 13(5):433-41. PubMed ID: 10897815
[TBL] [Abstract][Full Text] [Related]
39. Mercaptopurine/Methotrexate maintenance therapy of childhood acute lymphoblastic leukemia: clinical facts and fiction.
Schmiegelow K; Nielsen SN; Frandsen TL; Nersting J
J Pediatr Hematol Oncol; 2014 Oct; 36(7):503-17. PubMed ID: 24936744
[TBL] [Abstract][Full Text] [Related]
40. Cellular pharmacology of 6-mercaptopurine in acute lymphoblastic leukemia.
Bostrom B; Erdmann G
Am J Pediatr Hematol Oncol; 1993 Feb; 15(1):80-6. PubMed ID: 8447563
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
